Metformin dosage for longevity: every number is borrowed

Where the metformin dosage for longevity numbers come from

Early / mixed evidence The most concrete figure is the trial design: participants would take 1,500 mg daily over six years with multi-year follow-up.^[1] That amount is a standard therapeutic dose from diabetes practice, chosen for familiarity and tolerability rather than derived by testing doses against an aging outcome.^[2]

Clinics prescribing off-label mostly use the same range, typically starting at 500 mg and titrating toward 1,000 to 2,000 mg daily. Those are prescribing conventions carried over from a different indication.

It's the cheapest drug in the market. You can get 400 pills for 20 bucks.

Why no metformin dosage has been validated

Because the effect it is supposed to produce has not been demonstrated. A validated dose requires an endpoint to titrate against, and for aging in healthy people there is none.

The evidence has also moved unfavorably. A 2025 review noted that metformin given to mice from mid-life failed to produce significant lifespan benefits.^[3] A meta-analysis pooling 167 studies across vertebrate species found that dietary restriction and rapamycin extended lifespan consistently while metformin did not.^[4]

The human case rests largely on observational analyses suggesting people with diabetes taking metformin had mortality comparable to non-diabetic controls, a striking finding with obvious confounding.^[5]

What the human trials in older adults found

Not much, and one result deserves more attention than it gets. A trial giving 500 mg three times daily for four months to older adults with probable sarcopenia and frailty did not improve physical performance.

That is a negative result at a full therapeutic dose in exactly the population longevity prescribing targets. It does not settle the question and it belongs in any honest discussion of dosing.

The trade-off that scales with dose

A randomized trial in older adults found that metformin attenuated the improvement in insulin sensitivity and muscle mitochondrial adaptation produced by exercise training.^[6] Participants taking it got less out of the same workouts.

For someone with type 2 diabetes that trade is usually worth making. For a metabolically healthy person taking it speculatively while also training for healthspan reasons, it is a direct conflict between two parts of the same protocol, and it applies at ordinary doses.

If you are young and a bodybuilder and the muscle is important for you, don't take metformin.

Where the real dose limit sits

Kidney function, without qualification. Metformin is cleared renally, and reduced kidney function is either a contraindication or a dose limit depending on severity, because accumulation is what drives the rare serious risk of lactic acidosis. Prescribing guidance is explicit about checking this before and during treatment.

Below that ceiling, the practical limit is your digestive tract. Gastrointestinal effects are the usual reason people stop, which is why titration and extended-release formulations exist and why taking it with meals is standard advice.

The effect nobody notices without testing

Vitamin B12 depletion is the best-documented chronic effect of long-term use, it develops silently, and it is found only if someone checks. Anyone taking metformin indefinitely, particularly on their own initiative rather than for diabetes, should have B12 on the monitoring panel alongside kidney function and HbA1c.^[7]

How to read a metformin dosage recommendation

Ask what indication it came from. If the answer is diabetes, the number is doing a job unrelated to the reason you are considering it. If the answer is a longevity clinic, the number came from diabetes practice via a prescriber who has no outcome data either.

The honest summary is that the dose question is downstream of a larger one. Our page on what the metformin longevity evidence actually shows covers that, and the comparison with rapamycin explains why the two are no longer in the same evidential position. If you are training, the creatine page covers a cheaper intervention that helps training rather than blunting it.

Frequently asked questions

What is the metformin dosage for longevity?

There is no approved or validated one. The trial designed to test the question proposes 1,500 mg daily over six years, and clinics prescribing it off-label commonly use 500 mg to 2,000 mg daily. Those are protocol figures and prescribing conventions, not results.

How much metformin does the TAME trial use?

The design describes 1,500 mg daily with a multi-year follow-up. That figure was chosen as a standard therapeutic dose from diabetes practice, not derived from testing several doses against an aging endpoint.

How do doctors start metformin for anti-aging?

Typically low and slow: 500 mg daily or several times a week, increasing over weeks to reduce gastrointestinal upset. That titration manages tolerability. It does not identify an effective dose, because none has been identified.

Is 500 mg of metformin enough for longevity?

Enough for what is the missing half of the question. Doses at the lower end reduce gastrointestinal effects and no dose has been shown to slow aging in a healthy person, so there is nothing to be enough for yet.

Does metformin dosage depend on kidney function?

Absolutely, and this is the most clinically important part of any metformin conversation. Reduced kidney function is a contraindication or a dose limit depending on severity, because metformin is cleared renally and accumulation is what drives the rare serious risk.

Can healthy people take metformin?

Only by prescription and off-label. Diabetes journals have argued explicitly against extending metformin into prediabetes on the basis of the underlying risk profile, which is a more conservative position than most longevity clinics take.

Does metformin blunt exercise gains at any dose?

A randomized trial in older adults found metformin attenuated the improvement in insulin sensitivity and muscle mitochondrial adaptation from exercise training. That is a real trade-off and it applies at ordinary therapeutic doses.

Should metformin be taken with food?

Yes, with meals, which reduces the gastrointestinal effects that cause most people to stop. Extended-release formulations are also better tolerated than immediate-release at equivalent totals.

What monitoring goes with metformin?

Kidney function before starting and periodically after, and vitamin B12 over the longer term, since depletion is the best-documented chronic effect and goes unnoticed unless someone checks. HbA1c is usually monitored too.

Is 3,000 mg of metformin safe?

That is above the usual maximum in diabetes practice and would be an unusually high dose. Nothing about the longevity hypothesis argues for exceeding standard therapeutic amounts, and the risk profile worsens as the dose rises.

Did metformin extend lifespan in animals?

Not reliably, and this is the awkward center of the whole topic. A 2025 review noted that metformin given to mice from mid-life failed to produce significant lifespan benefits, and a large 2025 meta-analysis across vertebrates found no consistent effect.

Does the dose matter if the effect is unproven?

It matters for risk. Gastrointestinal effects, B12 depletion and the kidney limit all scale with exposure, so someone taking it speculatively is accumulating those at whatever dose they choose while the benefit remains hypothetical.

What about microdosing metformin?

No trial has tested sub-therapeutic dosing for any aging endpoint. It is a reasonable-sounding way to reduce side effects and there is no evidence that it retains any benefit, since no benefit has been established at full doses either.

What is the honest position on metformin dosage?

Every number in circulation is borrowed from diabetes practice. If you take it off-label, the practical questions are kidney function, B12 monitoring, and whether you are also training, because the exercise interaction is the most concrete downside anyone has measured.